NIFTY 50▼23,970.95
-24.40 (-0.10%)
SENSEX▼78,700.02
-82.22 (-0.10%)
NIFTY BANK▼51,191.50
-23.75 (-0.05%)
TATA MOTORS▲837.00
12.90 (1.57%)
SUZLON ENERGY▲66.57
0.25 (0.38%)
TATA STEEL▲150.18
3.23 (2.20%)
INDIAN RAILWAY FINANCE CORP▼150.30
-2.94 (-1.92%)
TATA POWER▲431.95
2.90 (0.68%)
RAIL VIKAS NIGAM▼445.10
-1.10 (-0.25%)
RELIANCE INDUSTRIES▼1,299.80
-2.35 (-0.18%)
VODAFONE IDEA▲8.17
0.29 (3.68%)
ZOMATO▼241.66
-3.42 (-1.40%)
RELIANCE POWER▼41.86
-0.17 (-0.40%)
INDIAN RENEWABLE ENERGY▼205.04
-0.34 (-0.17%)
ADANI POWER▲587.90
2.90 (0.50%)
YES BANK▲20.49
0.16 (0.79%)
STATE BANK OF INDIA▲835.15
5.30 (0.64%)
NHPC▼80.43
-2.87 (-3.45%)
HDFC BANK▼1,713.05
-1.05 (-0.06%)
OLA ELECTRIC MOBILITY LTD▼77.83
-3.01 (-3.72%)
JIO FIN SERVICES LTD▲320.60
0.75 (0.23%)
INDIAN OIL CORP▼138.43
-0.50 (-0.36%)
BHARAT ELECTRONICS▼280.50
-3.65 (-1.28%)
GTL INFRA▲2.18
0.07 (3.32%)
MRF▼1,19,700.75
-1176.00 (-0.97%)
ADANI PORT & SEZ▼1,311.05
-38.20 (-2.83%)
JAIPRAKASH POWER VENTURES▼17.84
-0.04 (-0.22%)
ITC▼480.35
-4.25 (-0.88%)
- Medicamen Biotech
Medicamen Biotech Share Price
MEDICAMEQ
₹533.85+₹0.65 (0.12%) TodayLast updated on 05 Nov, 2024 | 10:35 IST
Medicamen Biotech Share Price Chart
Please wait...
About Medicamen Biotech
Medicamen Biotech Financials
Market cap  ₹682 Crs | Open ₹530.00 | Close ₹533.20 |
Circuit range ₹639.80 - ₹426.60 | Day range ₹528.55 - ₹541.30 | Year range ₹355.45 - ₹689.55 |
Volume 7,026 | Avg. traded ₹535.78 | Revenue (12m) ₹180 Crs |
Medicamen BiotechMedicamen Biotech Limited is an India-based integrated pharmaceutical and life sciences solution provider company. The Company is engaged in research and development, manufacturing, marketing, and distribution of pharmaceutical products. The Company manufactures products across various therapeutic categories, including Pain Management, Cough and Cold, Cardiovascular and Central Nervous System, Anti-Diabetic, Gastrointestinal, Anti-Allergic, among others. The Company manufactures a range of products, including tablets, capsules, dry syrup, non-beta lactum, ointments, and creams. Its oncology products include Abiraterone acetate, Anastrozole, Bicalutamide, Bendmustine HCL, Bortezomib, Busulfan, Capecitabine, Cisplatin, Erlotinib HCL, Gefitinib, Imatinib mesylate, Letrozole, Melphalan, Oxaliplatin, Pazopanib, Its Cardiology products include Nifedipine Capsules, Atorvastatin Tablets, Fenofibrate Capsules, Rosuvastatin Tablets.
Medicamen Biotech Key indicators
52 week high ₹689.55 | 52 week low ₹355.45 | P/E ratio 66.09 |
P/B ratio 3.07 | ROE 6.85% | ROCE 10.13% |
Dividend yield 0.19% | Debt/Equity ratio 0.15 | EPS 10.46 |
Learn more
Featured in
Investment checklist: (1/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Medicamen Biotech Fundamentals
Medicamen Biotech Financial Ratios
Operating profit margin17.14% | Net profit margin7.71% |
ROE6.85% | ROA4.69% |
ROCE10.13% |
Learn more
Medicamen Biotech Shareholder returns
1 day -2.94% | 1 week | 1 month -6.89% |
3 months | 1 year -18.33% | 3 years -23.69% |
5 years -3.41% |
Medicamen Biotech Share Price history
| Day | Open | Close | Change % |
|---|---|---|---|
Mon, Nov 4 2024 | ₹548.95 | ₹533.20 | -2.94% |
Fri, Nov 1 2024 | ₹539.45 | ₹549.35 | |
Thu, Oct 31 2024 | ₹547.40 | ₹536.25 | -2.12% |
Wed, Oct 30 2024 | ₹485.05 | ₹547.85 | |
Tue, Oct 29 2024 | ₹494.50 | ₹486.75 | -1.73% |
Mon, Oct 28 2024 | ₹493.10 | ₹495.30 | -0.58% |
Fri, Oct 25 2024 | ₹486.40 | ₹498.20 | |
Thu, Oct 24 2024 | ₹495.80 | ₹481.05 | -3.48% |
Medicamen Biotech Shareholding Pattern
Promoters (42.99%) | Mutual Funds (0%) | Retail and other (55.77%) |
Foreign institutions-FII (0.06%) | Other domestic institutions (1.17%) |
Retail and other
Learn more
Events
Corporate actions
Dividend • ₹1/share
Ex date 19 Sep 2024
Dividend • ₹1/share
Ex date 20 Sep 2023
Dividend • ₹1/share
Ex date 19 Sep 2022
Learn more
More
Stocks Similar to Medicamen Biotech
People also bought
Medicamen Biotech News
